Global Porcine Epidemic Diarrhea Vaccines Market Analysis 2024: Size Forecast

The porcine epidemic diarrhea vaccines from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Porcine Epidemic Diarrhea Vaccines Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -
The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to large-scale vaccination campaigns, expanded programs on immunization (EPI), the adoption of disposable syringes, diarrhea eradication efforts, and initiatives like the global alliance for vaccines and immunization (GAVI).

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report 

Scope Of Porcine Epidemic Diarrhea Vaccines Market
The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Porcine Epidemic Diarrhea Vaccines Market Overview

Market Drivers -
The increasing pig farming is expected to propel the growth of the porcine epidemic diarrhea vaccines market going forward. Pig farming involves raising domestic pigs for meat production, breeding, rearing, managing from birth to market weight, and marketing and selling pork products. Pig farming is increasing due to rising global demand for pork products, improvements in breeding and management practices, technological advancements in farming techniques, and expanding markets for pork consumption. Porcine epidemic diarrhea (PED) vaccines are employed in pig farming to prevent and manage outbreaks. They are usually administered via injection or orally starting from the sow's gestation period to confer passive immunity to newborn piglets through colostrum. For instance, in December 2023, according to the United States Department of Agriculture, a US-based government department, around 75.0 million hogs and pigs were raised on American farms as of December 2023. Furthermore, in January 2022, according to the Department for Environment, Food & Rural Affairs, a UK-based government organization, pork on agricultural holdings increased to 4.08 million in December 2021 from 3.74 million in December 2020, a 9% rise. Therefore, the increasing pig farming is driving the growth of the porcine epidemic diarrhea vaccines market.

Market Trends -
Major companies operating in the porcine epidemic diarrhea vaccines market are developing innovative products, such as the porcine parvovirus (PPV) vaccine, to strengthen their position in the market. The Porcine Parvovirus (PPV) vaccine is a veterinary immunization designed to prevent reproductive failure in pigs caused by PPV, a small, non-enveloped virus associated with infertility, stillbirths, mummified fetuses, and weak piglets. For instance, in March 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine. This innovative vaccine is designed to combat reproductive failure in pigs, including infertility, stillbirths, mummified fetuses, and weak piglets caused by PPV, a small, non-enveloped virus. The uniqueness of this launch lies in the advanced formulation and efficacy of the vaccine, which offers comprehensive protection against PPV-induced reproductive losses, thereby safeguarding the health and productivity of pig herds.

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms

Get an inside scoop of the porcine epidemic diarrhea vaccines market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp 

Regional Insights -
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2023. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies -
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc

Table of Contents

1. Executive Summary
2. Porcine Epidemic Diarrhea Vaccines Market Report Structure
3. Porcine Epidemic Diarrhea Vaccines Market Trends And Strategies
4. Porcine Epidemic Diarrhea Vaccines Market – Macro Economic Scenario
5. Global Porcine Epidemic Diarrhea Vaccines Market Size and Growth
.
.
.
32. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Benchmarking
33. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market
35. Porcine Epidemic Diarrhea Vaccines Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 
Blog: https://blog.tbrc.info/ 
Healthcare Blog: https://healthcareresearchreports.com/ 
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model